Home > Insider Trading > Filing (0001209191-15-019816)

Filing Details

Accession Number:: 0001209191-15-019816
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-27 18:02:02
Reporting Period:: 2015-02-20

Filing Date:: 2015-02-27
Accepted Time:: 2015-02-27 18:02:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1103021	Biodelivery Sciences International Inc	BDSI	Pharmaceutical Preparations (2834)	352089858

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1066040	Jr E Francis Odonnell	C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Avenue, Suite 225 Raleigh NC 27612		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-02-20	70,000	$0.00	175,301	No	4	M	Direct
Common Stock	Disposition	2015-02-20	35,000	$14.37	140,301	No	4	S	Direct
Common Stock	Acquisiton	2015-02-22	48,419	$0.00	188,720	No	4	M	Direct
Common Stock	Disposition	2015-02-23	20,000	$14.56	168,720	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2015-02-20	70,000	$0.00	70,000	$0.00
Common Stock	Restricted Stock Units	Disposition	2015-02-22	48,419	$0.00	48,419	$0.00
Common Stock	Restricted Stock Units	Acquisiton	2015-02-23	400,000	$0.00	400,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
70,000	2015-02-20	2016-02-20	No	4	M	Direct
96,837	2015-02-22	2017-02-22	No	4	M	Direct
400,000		2018-02-23	No	4	A	Direct

Footnotes

The shares of common stock were acquired by the Reporting Person as a result of the vesting of 70,000 Restricted Stock Units ("RSUs") granted to the Reporting Person on February 20, 2013 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest on February 20, 2016.
The shares of common stock were sold under a pre-planned 10b5-1 trading plan, and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
On February 20, 2015, the Reporting Person sold an aggregate of 35,000 shares of the Issuer's Common Stock at a weighted average price of $14.37. The highest sale price for the Common Stock was $14.54 per share and the lowest sale price was $14.15 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 22, 2014 under the Issuer's 2011 Equity Incentive Plan, as amended. One-third of the RSUs under this grant will vest on each of, (i) February 22, 2016 and (ii) February 22, 2017.
On February 23, 2015, the Reporting Person sold an aggregate of 20,000 shares of the Issuer's Common Stock at a weighted average price of $14.56. The highest sale price for the Common Stock was $14.79 per share and the lowest sale price was $14.29 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The RSUs were issued to the Reporting Person on February 23, 2015, pursuant to a grant under the Issuer's 2011Equity Incentive Plan, as amended. One-third of the RSUs will vest on each of, (i) February 23, 2016, (ii) February 23, 2017 and (iii) February 23, 2018. Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.